Related Experiment Video
Updated: Aug 29, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Treatment of long, diffuse in-stent restenosis with sirolimus-eluting stents
Steven Siu-Lung Li1, Y C So, C H Wong
1Division of Cardiology, Department of Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong. listevensl@yahoo.com
Insights
Treating long, diffuse in-stent restenosis is challenging. Multiple sirolimus-eluting stents successfully treated a patient with this condition, showing good long-term patency and no major adverse events.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- In-stent restenosis (ISR) poses a significant challenge in coronary artery interventions.
- Long and diffuse ISR lesions are particularly difficult to treat effectively with current strategies.
Observation:
- This case report details the management of a patient with a long, diffuse in-stent restenotic lesion.
- The lesion required treatment with multiple sirolimus-eluting stents (SES) placed sequentially.
Findings:
- Successful implantation of three 33-mm sirolimus-eluting stents resulted in widely patent vessels.
- At six-month follow-up angiography, only 19% restenosis was observed in the most affected segment.
- No major adverse cardiovascular events, including stent thrombosis, occurred within the ten-month follow-up period.
Implications:
- The use of multiple SES may be a viable therapeutic option for complex, long, diffuse ISR.
- This approach demonstrates potential for achieving favorable long-term outcomes in challenging ISR cases.
- Further studies are warranted to validate this strategy in a larger patient cohort.
Abstract:
Treatment of long, diffuse in-stent restenosis remains a therapeutic challenge. We report the successful use of multiple sirolimus-eluting stents (three 33-mm long stents) in a long, diffuse in-stent restenotic lesion. No major adverse cardiovascular events, including acute/subacute/delayed stent thrombosis, were noted at ten months. Angiography at six months showed widely patent stents with 19% restenosis only at the worst segment.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Mitral Stenosis III: Medical Management
